Previous Close | 40.86 |
Open | 41.91 |
Bid | 42.41 x 200 |
Ask | 42.61 x 100 |
Day's Range | 41.34 - 42.91 |
52 Week Range | 22.11 - 53.18 |
Volume | |
Avg. Volume | 934,929 |
Market Cap | 2.805B |
Beta (5Y Monthly) | 1.56 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The heavy selling pressure might have exhausted for Celldex (CLDX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Celldex (CLDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Celldex (CLDX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.